A prospective, Phase IV, multi-center, open label, Single dose clinical study to demonstrate the safety and efficacy of DYSPORT in adult subjects for treatment of moderate-to-severe glabellar lines
Latest Information Update: 03 Jul 2019
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Adverse reactions
Most Recent Events
- 25 Mar 2019 New trial record